Mindset Pharma Presenting at H.C. Wainwright “Psychedelics in Psychiatry and Beyond” Virtual Conference
TORONTO– Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) announced that it has been invited to present at the H.C. Wainwright “Psychedelics In Psychiatry and Beyond” Virtual Conference being held on June 17, 2021.
James Lanthier, CEO of Mindset, commented, “Mindset is pleased to be invited to present at H.C. Wainwright’s conference. Mindset has expanded its next generation drug program to four distinct families of novel, patent-pending compounds with the goal of creating optimized therapeutics for a range of treatment modalities and indications. We are excited to share the Mindset story with a broader investor audience and thank H.C. Wainwright for the invitation.”
Forward-Looking Information
This news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “would”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
(This information is primarily sourced from Mindset. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here)
Latest News
German Cannabis Policy Reform Takes Center Stage at ICBC Berlin 2023
BERLIN-- The International Cannabis Business Conference (ICBC) is gearing up for a timely and significant political discussion on cannabis policy reform in Germany. Building on the historic panel discussion held in 2021, where all major ...
Cronos Group Inc. to Cease Hemp-Based CBD Operations in the U.S. and Focus on Cash Flow and Future THC Market Entry
TORONTO-- Canadian cannabis company Cronos Group Inc. has revealed plans to discontinue its hemp-derived CBD operations in the United States by the end of the second quarter of this year. The decision is aimed at ...
Multi-State-Operators Set to Enter NY Adult-Use Market After Policy Change
NEW YORK–In an effort to stabilize New York's adult-use marijuana program, which has experienced a rocky rollout, new legislation and significant policy shifts have been proposed. One of the key changes is the potential entry ...